Yüklüyor......

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting

Control of chemotherapy-induced nausea and vomiting (CINV) is a crucial factor in ensuring that patients undergoing cancer chemotherapy can get the full benefit of therapy. Current antiemetic guidelines recommend that the neurokinin-1 receptor (NK-1R) antagonist aprepitant should be used as part of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Celio, Luigi, Ricchini, Francesca, De Braud, Filippo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3653760/
https://ncbi.nlm.nih.gov/pubmed/23687442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S31288
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!